| Hydrogen sulfide and autophagy: A double edged sword D Wu, H Wang, T Teng, S Duan, A Ji, Y Li Pharmacological research 131, 120-127, 2018 | 88 | 2018 |
| Hydrogen sulfide as a novel regulatory factor in liver health and disease DD Wu, DY Wang, HM Li, JC Guo, SF Duan, XY Ji Oxidative Medicine and Cellular Longevity 2019, 2019 | 70 | 2019 |
| Synthesis of naphthalenes through three-component coupling of alkynes, fischer carbene complexes, and benzaldehyde hydrazones via isoindole intermediates S Duan, DK Sinha-Mahapatra, JW Herndon Organic letters 10 (8), 1541-1544, 2008 | 67 | 2008 |
| A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K/AKT/mTOR and Ras/Raf/MEK/ERK signaling pathways Q Dong, B Yang, JG Han, MM Zhang, W Liu, X Zhang, HL Yu, ZG Liu, ... Cancer Letters 455, 60-72, 2019 | 66 | 2019 |
| Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells Y Zhao, S Duan, X Zeng, C Liu, NM Davies, B Li, ML Forrest Molecular pharmaceutics 9 (6), 1705-1716, 2012 | 64 | 2012 |
| Hydrogen sulfide alleviates lipopolysaccharide-induced diaphragm dysfunction in rats by reducing apoptosis and inflammation through ROS/MAPK and TLR4/NF-κB signaling pathways GY Zhang, D Lu, SF Duan, YR Gao, SY Liu, Y Hong, PZ Dong, YG Chen, ... Oxidative medicine and cellular longevity 2018, 2018 | 50 | 2018 |
| Multi-arm polymeric nanocarrier as a nitric oxide delivery platform for chemotherapy of head and neck squamous cell carcinoma S Duan, S Cai, Q Yang, ML Forrest Biomaterials 33 (11), 3243-3253, 2012 | 49 | 2012 |
| Lewis Acid-catalyzed diastereoselective hydroarylation of benzylidene malonic esters S Duan, R Jana, JA Tunge The Journal of organic chemistry 74 (12), 4612-4614, 2009 | 43 | 2009 |
| Lysosomotropic properties of weakly basic anticancer agents promote cancer cell selectivity in vitro RA Ndolo, Y Luan, S Duan, ML Forrest, JP Krise PloS one 7 (11), e49366, 2012 | 41 | 2012 |
| Role of hydrogen sulfide donors in cancer development and progression EE Ngowi, A Afzal, M Sarfraz, S Khattak, SU Zaman, NH Khan, T Li, ... International Journal of Biological Sciences 17 (1), 73, 2021 | 38 | 2021 |
| Nanomedicine: A Promising way to manage Alzheimer’s disease NH Khan, M Mir, EE Ngowi, U Zafar, MMAK Khakwani, S Khattak, YK Zhai, ... Frontiers in Bioengineering and Biotechnology 9, 630055, 2021 | 37 | 2021 |
| Roles of hydrogen sulfide donors in common kidney diseases EE Ngowi, M Sarfraz, A Afzal, NH Khan, S Khattak, X Zhang, T Li, ... Frontiers in pharmacology 11, 564281, 2020 | 36 | 2020 |
| Impact of molecular weight on lymphatic drainage of a biopolymer-based imaging agent TR Bagby, S Cai, S Duan, S Thati, DJ Aires, L Forrest Pharmaceutics 4 (2), 276-295, 2012 | 36 | 2012 |
| Targeted self-activating Au-Fe3O4 composite nanocatalyst for enhanced precise hepatocellular carcinoma therapy via dual nanozyme-catalyzed cascade reactions X Wang, T Xiong, M Cui, X Guan, J Yuan, Z Wang, R Li, H Zhang, S Duan, ... Applied Materials Today 21, 100827, 2020 | 34 | 2020 |
| A54 peptide-mediated functionalized gold nanocages for targeted delivery of DOX as a combinational photothermal-chemotherapy for liver cancer S Huang, C Li, W Wang, H Li, Z Sun, C Song, B Li, S Duan, Y Hu International Journal of Nanomedicine, 5163-5176, 2017 | 33 | 2017 |
| CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy Y Zhao, T Zhang, S Duan, NM Davies, ML Forrest Nanomedicine: Nanotechnology, Biology and Medicine 10 (6), 1221-1230, 2014 | 33 | 2014 |
| Better reporting and awareness campaigns needed for breast cancer in Pakistani women NH Khan, SF Duan, DD Wu, XY Ji Cancer Management and Research, 2125-2129, 2021 | 31 | 2021 |
| Triple therapy of hepatocellular carcinoma with microRNA-122 and doxorubicin co-loaded functionalized gold nanocages S Huang, Y Liu, X Xu, M Ji, Y Li, C Song, S Duan, Y Hu Journal of Materials Chemistry B 6 (15), 2217-2229, 2018 | 31 | 2018 |
| Gold nanocages with dual modality for image-guided therapeutics S Bao, S Huang, Y Liu, Y Hu, W Wang, M Ji, H Li, NX Zhang, C Song, ... Nanoscale 9 (21), 7284-7296, 2017 | 31 | 2017 |
| Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer C Li, C He, Y Xu, H Xu, Y Tang, H Chavan, S Duan, A Artigues, ML Forrest, ... The Prostate 79 (6), 628-639, 2019 | 28 | 2019 |
